Search Results
Viewing: 821-830 of 3169 | All
Article
Exceptional Responders
The National Cancer Institute (NCI) has embarked on the Exceptional Responders (ER) Initiative to understand the molecular underpinnings of exceptional responses to treatment, primarily via chemotherapy, in cancer patients.
Article
GMP Facility
The cGMP Clinical Manufacturing Facility is located at Andelyn Biosciences, an affiliate company of Nationwide Children's Hospital.
Article
Stanton Lab
Under the direction of Benjamin Stanton, PhD, the Systems Epigenetics Group is a highly collaborative group, focusing on pediatric cancer epigenetics and genomics.
Article
PIVOTAL Network
The PIVOTAL Network is a group of healthcare providers, institutions, and researchers working in collaboration to determine the best approach to treat preterm infants diagnosed with patent ductus arteriosus, commonly referred to as a PDA.
News
New Study Finds Alarming 15-fold Increase in Inflatable Bouncer-Related Injuries Among Children
A new study by researchers at the Center for Injury Research and Policy of The Research Institute at Nationwide Children’s Hospital examined pediatric injuries associated with inflatable bouncers, such as bounce houses and moonwalks.
News
National Study Finds Rising Rate of Marijuana Exposure Among Children 5 Years Old and Younger
Debates about legalizing marijuana have focused on crime rates, economic benefits, and health effects among adults. But a study published today from researchers at Nationwide Children’s Hospital shows that the risk to young children of swallowing, breathing in or otherwise being exposed to
News
Early Phase Gene Therapy Study for SMARD1/CMT2S Disease Now Enrolling
Nationwide Children's Hospital has launched a new Phase I/IIa gene replacement clinical study to evaluate the safety of a gene therapy for IGHMBP2-related diseases, specifically spinal muscular atrophy with respiratory distress type 1 (SMARD1) and Charcot Marie Tooth disease type 2S (CMT2S). SMARD1 and CMT2S are rare inherited conditions that are both caused by mutations in the IGHMBP2 gene, of which more than 60 have been found to date. SMARD1 is the most severe form of these diseases and causes muscle weakness and respiratory failure in infancy.
News
Bellville, Ohio, Teen and Family Travel to Capitol Hill to Advocate for Pediatric Cancer Research
The Reed family of Bellville, Ohio, is taking their story to Capitol Hill to deliver an important message to their members of Congress. Nationwide Children’s Hospital patient, Grant Reed, 15, and his family will join more than 40 other pediatric patients and their families to meet with
Article
Computational Genomics
The “big data” nature of genome-based clinical tests and research studies requires advanced high-performance computing and bioinformatics platforms to rapidly analyze and interpret information.
Blog
How Clinical Studies Get Approved by the FDA and Why That Is Important
From lab to pharmacy shelf, every new treatment goes through rigorous testing before earning FDA approval. Learn how clinical trials work, the four phases of research, and why each step is essential to ensuring safe, effective medical breakthroughs.